Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Non-animal testing methods could save drugmakers time and money, officials say ...

Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...

The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...

Stem Pharm, a Madison biotech startup, is using lab-created 3D "organoids" to develop a treatment for Alzheimer's disease. In April, the FDA and NIH announced plans to incentivize so-called "new ...

The FDA has released draft guidance aimed at helping drug developers shift away from traditional animal testing as the ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new ...

Last November, the UK government announced a bold plan to phase out animal testing in some areas of research. Animal tests for skin irritation are scheduled for elimination this year, and some studies ...

The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal antibody therapies and other drugs and biological products “with ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...

There’s one area of surprising agreement in the often adversarial relationship between conservatives and the scientific community: the need to phase out animal testing in biomedical research. The new ...